A clinical study of Kopuranthangi chooranam in the management of Thandagavatham

A clinical study of Kopuranthangi chooranam in the management of Thandagavatham Lumbar spondylosis among patients attending OPD,GSMC, Palayamkottai - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/095322

Enrollment

Registered

2025-09-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

Intervention1: Kopuranthangi chooranam: Ingredients Kopuranthangi Andrographis echiodes Dose 2gm bd with cow ghee Duration 48 days Route of administration oral route Control Intervention1: Not applica

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with symptoms Low back pain that radiates to both lower legs. Stiffness Limited range of motion Tingling or numbness in the legs Weakness in lower limbs Difficulty walking, bending forward or standing for long periods Imaging tests showing degeneration, osteophyte formation, disc bulge

Exclusion criteria

Exclusion criteria: Pregnant women and lactating women Ankylosis spondylosis Malignancy Spinal tuberculosis

Design outcomes

Primary

Measure	Time frame
Efficacy of Kopuranthangi chooranam in the management of Thandagavatham (Lumbar spondylosis) will be evaluatedTimepoint: 4 months	—

Secondary

Measure	Time frame
Prognosis of diseases is assessed using likert scale Timepoint: 4 months	—

Countries

India

Contacts

Public ContactDr S Sundararajan

Government siddha medical College and hospital

Soundsundar12@gmail.com9443423937

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026